Summary, To evaluate the acute effects of intravenous insulin on myocardial contractility and heart rate, echocardiography was performed in 12 healthy subjects and continuous heart rate recording in 11 healthy subjects before and during euglycaemic insulin and glucose infusion. The rate of insulin infusion was 0.5-1.0 mU-kg-1. min-1. Serum insulin concentration was increased from 14.1 + 5.5 (mean _+ SD) to a plateau level of 91.3 + 22.8 mU/1. Left ventricular end-diastolic diameter, ejection phase indices and the heart rate remained at basal levels during the intervention. Thus moderate hyperinsulinaemia, induced by euglycaemic insulin and glucose infusion, has no inotropic or chronotropic effects in healthy supine subjects.
Intravenous insulin has been claimed to increase heart rate in normal subjects and in patients with diabetes mellitus, particularly in the upright position [1] [2] [3] [4] [5] . Experimental studies on lambs and cats have shown that intravenous insulin increases myocardial contractility, an effect which was not dependent on glucose or catecholamines [6] [7] . However studies on dogs and rats have failed to demonstrate a positive inotropic effect in either intact hearts or isolated cardiac muscle [8] [9] [10] . In patients with myocardial infarction combined glucoseinsulin-potassium infusion improves global ejection fraction and ejection fraction in the ischaemic zone [11] . Insulin-induced hypoglycaemia is also associated with marked inotropic and chronotropic effects in man [12] .
The purpose of the present study was to evaluate whether intravenous insulin has any acute effects on myocardial contractility and heart rate in healthy subjects. In contrast to most previous studies we used the euglycaemic clamp technique to avoid a decrease in blood glucose levels, which might activate counter-regulatory systems and so indirectly affect cardiac function.
tee of Oulu University. Subjects were physically fit (many of them sports enthusiasts) and none had a family history of diabetes. Their body mass indices ranged from 16.8 to 24.7 kg/m 2 (mean 22.0 kg/m2).
Hyperinsulinaemia
Acute hyperinsulinaemia was achieved with the euglycaemic clamp technique [13] as described previously [14] . Subjects were studied in the postabsorptive state after an overnight fast and 1 h supine rest. An intravenous cannula was inserted into an antecubital vein for glucose and insulin infusions. A second catheter was inserted into a dorsal hand vein of the opposite hand for blood sampling. A loading dose plus a continuous infusion of crystalline semi-synthetic human insulin (Actrapid HM, Novo, Copenhagen, Denmark) was given. The loading dose was infused in a logarithmically decreasing manner for 10 min to reach a hyperinsulinaemic level. The continuous infusion of insulin was begun at 10 min and continued up to 120 min to maintain hyperinsulinaemia. The rate of continuous insulin infusion was 0.5-1.0 mU. kg -1. min -1. This protocol results in an initial overshoot in plasma insulin concentration that lasts about 20 rain and is followed by a plateau plasma insulin level [13] . The blood glucose was maintained at the euglycaemic level by the determination of blood glucose every 5 min and adjustment of the infusion rate of a 20% glucose solution. Samples for serum immunoreactive insulin determinations were taken before the infusion and every 10 min during the infusion, starting 20 min after the onset of infusion.
Subjects and methods

Subjects
Seventeen healthy medical students (12men, 5women), aged 21-34years (mean 24years), volunteered for the study and gave informed consent. The protocol was approved by the Ethical Commit-
Chemical methods
Blood glucose concentration was determined immediately using a reflolux strip test (BM-Test-BG, Boehringer Mannheim, Mannheim, FRG), and checked with a hexokinase method (Glucoquant, Boehringer Mannheim). Serum insulin concentration was determined by a RIA kit (Coat-A-Count, Diagnostic Products Corporation, Los Angeles, California, USA). Plasma concentrations of noradrenaline and adrenaline were determined by radioenzymatic assay [15] in 6 subjects (4 of whom took part in the echocardiographic study) before and at 30 min after the beginning of insulin infusion.
Echocardiography
Echocardiography was performed in 12 of the subjects (8men, 4 women) immediately before and at 10, 20, 30 min (and 60 min in shortening of the minor axis and heart rate determined from the R-R intervals of the echocardiograms in 12 healthy subjects before and during insulin infusion 4 subjects) after the beginning of the insulin infusion. Echocardiograms were obtained with an ATL Mark III real-time echocardiographic system (Bellevue, Washington, USA) using a mechanical sector transducer with a 90 ~ angle and a frequency of 3.0 mHz. The Mmode echocardiogram, ECG, and a carotid pulse tracing were recorded with a fibreoptic recorder (Honeywell, Denver, Colorado) on ultraviolet paper with a speed of 100 mm/s using an accurate standard technique routinely employed in this laboratory [16] . By reviewing previous records, similar sites just distal to the tip of the anterior mitral leaflet were selected for serial measurements. The left ventricular end-diastolic diameter (LVEDD) and end-systolic diameter (LVESD) were measured according to the recommendations of the American Society of Echocardiography [17] . The fractional shortening of the left ventricular minor axis in systole was calculated as (LVEDD-LVESD) • 100/LVEDD and the mean velocity of the left ventricular circumferential fibre shortening as (LVEDD-LVESD)/ LVEDD x LVET, where LVET is left ventricular ejection time measured from the simultaneously recorded carotid pulse tracing. Heart rate during echocardiographic recordings was derived from the R-R intervals on the ECG. All measurements were made from approximately 10 consecutive or nearly consecutive cardiac cycles without knowing the subject's clinical data. The difference between duplicate echocardiographic measurements (n= 28) was as follows: LVEDD, 0.6 + 0.7 mm; fractional shortening of minor axis, 1.4 + 1.4%; mean velocity of circumferential fibre shortening, 0.05+0.04 circumference, sec-4.
Heart rate recording
Continuous heart rate recording was performed in a supine position in 11 subjects (7 men, 4 women), six of whom also took part in the simultaneous echocardiographic study. The heart rate was determined with a microcomputer pulse transmitter (Sport Tester PE 2000, Polar Electro, Kempele, Finland), which continuously measures the heart rate and records the data in memory for later gmalysis and processing [18] . From these data the mean heart rate of successive 10-min periods was determined in each subject. Heart rate monitoring was started 20 min before the insulin infusion, when the catheters were inserted and when the subjects had already rested at least 30 min in a supine position. Fig.2 . The mean heart rate of successive 10-min periods in 11 healthy subjects before and during insulin infusion Results expressed as mean _+ SD
Statistical analysis
Differences between repeated measurements were tested using the non-parametric statistical method of Friedman two-way analysis of variance and the Wilcoxon test. All data are expressed as mean +_ SD.
Results
The insulin infusion raised the serum insulin concentration from 14.1_+5.5 to a plateau level of 91.3_+ 22.8 mU/1. The blood glucose level during the intervention was 4.9 _+ 0.4 mmol/1 with a coefficient of variation of 7.3 + 2.1%. The mean volume of glucose infused during the first 30 min was 87 -+ 20 ml and during the subsequent 30 min periods 105 -+ 26 ml.
In the echocardiographic study of 12 subjects, left ventricular end-diastolic diameter and the ejection phase indices remained at basal levels during the insulin infusion (Table 1 , Fig. 1 ). Continuous heart rate recording in 11 subjects revealed no change in heart rate during the infusion (Fig. 2) .
No significant changes in plasma concentrations of catecholamines were observed. The adrenaline concentration before insulin infusion was 0.23 _+ 0.05 and during the infusion 0.24_+ 0.06 nmol/1. The noradrenaline concentrations were 1.81 _+ 0.49 and 1.70 ___ 0.50 nmol/1 respectively.
Discussion
Evaluation of the effects of insulin on cardiovascular function is complex, since insulin may influence cardiac function through several indirect mechanisms. Hypoglycaemia, or even a slight decrease in blood glucose levels, may activate glucose counter-regulatory systems [19] . Furthermore high doses of intravenous insulin increase plasma noradrenaline independent of changes in blood glucose [3] . Insulin also impairs the inotropic action of noradrenaline on the heart [7] . The insulin-induced reduction in effective circulatory blood volume may also increase heart rate, particularly in the upright position. Reports concerning plasma volume changes are, however, conflicting and the observed reductions may be secondary to a-adrenergic stimulation [12, [20] [21] [22] .
To avoid these indirect effects of insulin we produced hyperinsulinaemia using euglycaemic glucose and insulin infusion. The insulin infusion level employed was comparable to that recommended for patients with myocardial infarction [11] and was not so high as to induce an elevation in plasma catecholamines [19] . Myocardial contractility was assessed by M-mode echocardiography, which has the limitation of monitoring only a small part of the left ventricle. It is, however, a reproducible standard technique suitable for serial studies in young subjects such as these, since they all had high quality recordings and symmetrical wall mo-651 tions in simultaneous two-dimensional study [23] [24] . A relatively short echocardiographic observation time was chosen, since earlier experimental and clinical studies have shown a maximal cardiac effect within 30 min of insulin administration [6] [7] 12] .
Fractional shortening of the left ventricular minor axis and the mean velocity of circumferential fibre shortening directly reflect myocardial contractility, since neither pre-load (left ventricular end-diastolic diameter), after-load (systolic blood pressure) nor heart rate changed significantly during the recordings (Table 1) . These ejection phase indices remained virtually unchanged throughout the intervention and the minor fluctuations in the values were within the limits of reproducibility (Fig.l) [23, 25] . Plasma volumes were not determined in these subjects, but the unchanged left ventricular end-diastolic diameter suggests indirectly that no marked change in effective plasma volume occurred during the infusion [26] .
Rowe et al. [3] measured the heart rate using an ann cuff technique at regular intervals in 12 healthy subjects and observed a heart rate rise of 0-7.5 beats/min during 2 mU and 5 mU euglycaemic insulin infusions. In contrast to their findings no insulin-induced increase in heart rate was observed in these healthy subjects. Differences in measuring technique and in insulin doses may explain the discrepancy.
Earlier studies in diabetic subjects have demonstrated a heart rate rise of 4-9 beats/min after intravenous insulin without a euglycaemic clamp technique [1, 2, 4] . At least two factors may contribute to the difference in the heart rate response to insulin between diabetic and healthy subjects. Firstly a decreasing blood glucose level, even without hypoglycaemia, may activate the glucose counter-regulatory systems of diabetic subjects which alone may raise the heart rate [19] . Secondly it is possible that the cardiovascular effects of insulin are dependent on the pre-existing insulin level. Hence responses observed during insulin deficiency may not be applicable in healthy subjects. This might, together with a wide range of insulin doses, also explain the variable inotropic responses observed in experimental studies dealing with either non-diabetic or alloxandiabetic insulin-deficient animals [6, 9, 27] . It is questionable that the use of human insulin contributed to our negative findings although pork insulin and mixed beef-pork inulin preparations have been shown to have divergent inotropic actions in experimental studies [28] .
In conclusion, moderate hyperinsulinaemia, induced by intravenous insulin infusion with a euglycaemic clamp technique, had no inotropic or chronotropic effects in healthy supine subjects. Our negative findings do not exclude potential cardiovascular effects of higher, supraphysiological hyperinsulinaemia which also resuits in a rise in plasma catecholamines.
